New Yorker essay shines a spotlight on the scourge of autoimmune disease

Utah 2013 aes  - 080

For autoimmune patients—and I’m one of them—life sometimes feels like a lonely uphill climb:

“getting sick for no good reason, falling prey to esoteric infections and mysterious skin outbreaks, sliding into spells of lethargy and exhaustion that looked so much like laziness it was maddening.”

Excerpt from A Stroke of Bad Luck and the Potholed Road to Recovery

In her essay “What’s Wrong With Me” published in this week’s New Yorker (Aug. 26, 2013), author Meghan O’Rourke shines a spotlight on what it’s like to live with autoimmune disease. Recounting experiences all too familiar to autoimmune patients, and to me, O’Rourke describes:

  • symptoms ranging from hives to migraines, buzzing in her throat, numbness in her feet;
  • terrible fatigue that made her feel like “a mechanism that moved arduously through the world, simply trying to complete its tasks. Sitting upright at my father’s birthday party required a huge act of will.”
  • her brain often “enveloped in a thick gray fog”
  • a susceptibility to viruses (in her case cytomegalovirus, parvovirus, and Epstein-Barr)
  • a family history sprinkled with various seemingly unrelated illnesses that (she learned later) are all autoimmune in nature.

 

Like many autoimmune patients, O’Rourke rattled from doctor to doctor for years before any of them believed she had a disease.  “Many clinicians assume that the patient, who is often a young woman, is just one of the ‘worried well,’” she writes. Finally, after six years, she had her diagnosis: autoimmune thyroiditis, often called Hashimoto’s, the same disease that plagued my grandmother.

I missed the the doctor-to-doctor crawl because I had no clue that my body was harboring any kind of illness until I was felled by a stroke caused by my particular autoimmune disease: antiphospholipid syndrome (APS).

O’Rourke writes movingly about what it’s like to struggle with a debilitating condition—autoimmunity—that no one, even specialists, understands well.

The lack of knowledge is shocking to me, considering the magnitude of the problem: The American Association of Autoimmune Related Diseases (AARDA) estimates that as many as fifty million Americans suffer from autoimmunity—a greater number than cancer.  

 

There are somewhere between eighty and one hundred autoimmune diseases, yet “autoimmune disease is as much of a medical frontier today as syphilis or tuberculosis was in the nineteenth century,” O’Rourke writes. “Some researchers say the number of cases is rising at almost epidemic rates.”

At times during the course of searching for a diagnosis and treatment of her illness O’Rourke questioned her own sanity:

  • “Was I going mad?” she asks.
  • “The worst part of my fatigue, the one I couldn’t explain to anyone—I knew I’d seem crazy—was the loss of an intact sense of self.”
  • “To be sick in this way is to have the unpleasant feeling that you are impersonating yourself.”

 

“It was a struggle,” she writes, “to do anything—to teach my class, to tidy the house, to go to the gym. My joints hurt, my neck hurt; I had nosebleeds and large bruises up and down my legs. I spend hours everyday unable to work …” This situation is all too familiar to me and other autoimmune patients.

Like many who suffer from autoimmunity, O’Rourke found information and solace in on-line support groups, “people, rich and poor, who were connected by one thing: the inability of doctors to alleviate their symptoms.”   She also turned to diet hoping to mediate her disease. She followed a diet similar to the so-called Paleo regimen: “no gluten, no refined sugar, little dairy” so strictly that, while it did ease some of her symptoms, she spent “at least half of each day” shopping for food, eating, and cleaning up.

“What I had wasn’t just an illness now; it was an identity, a membership in a peculiarly demanding sect. I had joined the First Assembly of the Diffusely Unwell …”

But O’Rourke realized that she didn’t want her life to be defined by illness.

Echoing the concern of many autoimmune patients, she writes: “I worried that I would no longer have friends.”

“The chronically ill patient has to hold in mind two contradictory modes: insistence on the reality of her disease, and resistance to her own catastrophic fears.” Amen to that.

CV1_TNY_08_26_13Drooker.inddO’Rourke’s thoughtful essay has much more to say about autoimmune disease and her experience.  Anyone concerned about the scourge of autoimmunity should read it.  If you’re not a New Yorker subscriber, you can find this issue at newsstands this week, or order a single copy from The New Yorker here.

Genetic Basis Identified for Type of Migraine That Increases Stroke Risk

A research team at the University of California, San Francisco (UCSF), has identified a genetic mutation that is strongly associated with a typical form of migraine headache—migraine with aura.  The research “puts us one step closer to understanding the molecular pathway to pain in migraine,” according to Louis J. Ptáček, senior investigator on the study and a professor of neurology at UCSF. “And, as we come to a clearer understanding, we can start thinking about better therapies,” he said.

The mutation is in the gene known as casein kinase I delta (CKIdelta). You can read more about the research here.

Could that mean that, one day, genetic testing can help identify people who are at increased for stroke? I hope so. I was one of them

I suffered from relatively mild migraines for twenty years before I had a stroke. Though mild, my migraines were the type of migraine the UCSF study describes: with “aura,” that strange visual disturbance that always preceded the headache—blind spots,  zigzag lines or flashing dots that seemed to pulse before my eyes. Once I saw the aura, the rest would be only minutes behind—the pounding headache, over-sensitivity to light and sound, sometimes nausea. I knew women who had migraines so severe they had to stay home from work and retreat to a dark room in agony. Fortunately mine weren’t that bad.

But—though I didn’t know it at the time—even these mild migraines put me at significantly increased risk for stroke.

Women who suffer from migraines with aura (visual disturbances such as flashing dots or blind spots) can be up to ten times more likely to suffer a stroke, depending on other risk factors, according to Dr.  Steven J. Kittner, professor of neurology and director of the Maryland Stroke Center, University of Maryland School of Medicine.

Migraine is also one of the symptoms of the clotting disorder that caused my stroke, an autoimmune disease I never knew I had until I was slammed by a stroke at forty-eight years old. It’s called Antiphospholipid Syndrome or APS.  APS is also sometimes called “sticky” blood because it makes the blood “thicker” and more prone to clots. After my stroke more than ten years ago, I was put on blood thinners for life. I haven’t had a migraine since. It almost seems to me like the headache signaled my sludgy blood struggling flow through my brain. Until it got stuck and formed a clot that caused a stroke that reordered my life.

I want to get the word out about migraine. If you have them, you’re at increased risk for stroke. Do your brain a favor: evaluate any other risks for stroke you have, and try to reduce them.

Risk factors are cumulative,” Dr. Kittner adds.  “Reducing even one risk can greatly lower your chances of having a stroke.”

Read more about the risk factors for stroke here in this list from the National Stroke Association.

 

 

 

Can Statins Help Treatment of Antiphospholipid Syndrome?

New research suggests that statins, traditionally used for cholesterol lowering, could be used in the management of patients with antiphospholipid syndrome (APS), a blood clotting disorder that causes miscarriages, deep vein thromboses, and strokes.

The new research shows that the statin fluvastatin could reduce the inflammatory proteins that are elevated in patients with APS.

The research, by a joint team from the Special Surgery in New York City and the University of Texas Medical Branch, Galveston, Texas, was presented November 12, 2012, at the American College of Rheumatology/Association of Rheumatology Health Professionals  meeting in Washington, D.C.

Read more about the research here: http://bit.ly/UbJ03c

The anti-malarial drug Plaquenil has been used for years in treatment of APS. It helps to reduce the antibodies that are the primary cause of APS patients’ tendency to produce blot clots when they shouldn’t. I’ve been taking Plaquenil for antiphospholipid syndrome for ten years.  After my stroke, my doctor hoped it would help lower my antibodies, but estimated it would take several years. She was right. After about four years, the antibodies started to fall. Not long after that, I noticed I was feeling better, with fewer flares and low-energy days.

It will be interesting to see how well statins work and what the advantages might be.

Do you have any experience with statins?

 

 

 

New Video Explains Antiphospholipid Syndrome

Anisur Rahman

Professor Anisur Rahman of University College, London, discusses the latest thinking on Antiphospholipid Syndrome, its causes and treatments in a 35-minute lecture delivered October 10, 2012, at the Royal Society of Medicine. The easy-to-understand video presentation, with slides, is available here(http://bit.ly/VORFdC)

It’s a great resources to help educate physicians, patients, and their families.
Antiphospholipid Syndrome or APS (sometimes called Hughes Syndrome) is an autoimmune disease that causes blood clots, miscarriages, and strokes. APS is the most common cause of acquired thrombophilia (the tendency to produce blood clots when one shouldn’t  because of a genetic or immune system abnormality).
As Professor Rahman explains, APS is the cause of thirty percent of strokes in people under 50. I was one of those.

If you or anyone you know is affected by APS, this is a great learning tool.

Migraine and Stroke: What You Need to Know

This month the National Stroke Association is sharing information about migraine and stroke, including an article from the Better Health Channel on how to tell the difference between the two.

I had mild migraines (with aura) for 20 years, which I dismissed as a mere annoyance. Until I had a stroke at 48, and learned (too late) that migraines are a symptom of the clotting disorder antiphospholipid syndrome (APS), which was the cause of my stroke.

“Migraine and stroke have many symptoms in common,” says Tina Pohlman of the APS Foundation of America, “but there are also important differences.”

People need to know the difference between migraine and stroke. They also need to know that people who have migraines with aura have a much higher risk of stroke.

Recent research shows that migraine is an important risk factor for stroke.  Women who suffer from migraines with aura (visual disturbances such as flashing dots or blind spots) can be four or five times more likely to suffer a stroke.

But, according to Steven J. Kittner, M.D., director of the Maryland Stroke Center, “risk factors are cumulative.”

For example, women who take even a low-estrogen birth control pill are twice as likely to have a stroke than those who don’t. If they also suffer from migraines, their risk of stroke catapults to eight or ten times normal. That is exactly what happened to me.

For people who have high blood pressure or diabetes (which thankfully I did not) the risks are even higher. I’d call them astronomical, but that’s just me, looking at stroke risks from the other side, knowing that, if I’d known more, my stroke might have been prevented.

Here’s more on the link between migraine and stroke, from MSNBC.

Get the scoop on APS, the clotting disorder than caused my stroke

I was slammed out of the blue ten years ago by a stroke that could have been prevented if I’d know the facts. Don’t let that happen to you or someone you love. Today, June 9, is APS awareness day – APS, the acronym for Antiphospholipid Syndrome, the blood clotting disorder that caused my stroke. It’s a great day to start learing the facts.

I remember feeling like the doomed heroine of a bad sci-fi when I first learned the cause of my stroke – an unpronounceable, incomprehensible disease: ‘Antiphospholipid Syndrome,’ or APS. I’d never heard of APS. Nobody I knew had ever heard of APS, even most of my doctors had never heard of APS.”

 APS can be life threatening.

Here are the facts:
• APS is a blood clotting disorder. In patients with APS, the body releases antibodies that cause the blood to clot when it shouldn’t
• As a result, APS is a common cause of miscarriage, blood clots in the legs (deep vein thrombosis), the lungs (pulmonary embolism), heart attack, and stroke.
• It’s also an autoimmune disease. Like lupus and other autoimmune diseases, APS can “flare” at times, causing weakness, fatigue, achy muscles and joints, especially when we’re are tired or stressed.
• APS is sometimes found in conjunction with other autoimmune diseases, particularly as lupus.

You may not have heard about APS, either, but you need to know.

Here’s why:

• One third of strokes occurring in people under 50 are due to APS. Mine was one of those.
• Estrogen in the form of birth control pills and hormone replacement–perfectly safe for most women–can be deadly for women with APS.
• It’s estimated that 15-20% of blood clots in large veins (deep vein thrombosis, including pulmonary embolism) are caused by APS.
• Some 10-25% of women with recurrent miscarriages have APS. If properly diagnosed and treated, many of them can have healthy full-term babies.
• APS is a major women’s health issue: 75-90% of those affected by APS are women
• APS isn’t rare. It’s estimated that one to five percent of the general population has APS.

That’s about two to six million women, comparable to the number of women living with cancer.

Awareness is growing. When I started trying to research APS in 2002, shortly after my stroke, the only information I could find was a booklet from the Hughes Foundation in England and Medline articles heavy on doctor-speak.

My resource page  has further information about APS. Even more information is available from  the APS Foundation of America as well as trusted medical sites like the Mayo Clinic, the the National Institute of Neurological Disorders and Stroke (NINDS), and genome.gov. APS now even has its own Wikipedia page.

There are also several on-line support groups:  the Antiphospholipid Syndrome International Support Group (APLSUK) based in the UK, and APS-Syndrome, both run through YAHOO, and the  support forum sponsored by the APS Foundation of America.

Be informed and share information about APS with the women in your life.

Don’t Miss This Nov. 14 Book Party Celebrating All Things Wild

Anne in Guatemala

 

It’s a jungle out there and I just can’t get enough of it!

Come help me celebrate publication of my story “Why I Still Travel to the Wild” at a book party sponsored by Left Coast Writers. It’s  on Monday evening, November 14, at 6 pm at Book Passage San Francisco store at the SF Ferry Building. (Just one block from Embarcadero BART.)

My story is a reflection on my (some might say stubborn)  determination to continue traveling to remote corners even after my health was compromised by a stroke and autoimmune disease. It’s just out in the  new anthology Chicken Soup for the Soul: Find Your Happiness. 

Join us for wine,  hors d’oeuvres and jungle-y treats plus, reading and a drawing for prizes.  Fellow author Nicole Guiltinan will join me.  It’s free and open to the public. Great opportunity to start your holiday shopping!

Address: Book Passage, 1 Ferry Building, San Francisco, CA 94111    Book Store phone: (415) 835-1020

 

Don’t be a Statistic: Learn the Facts About Antiphospholipid Syndrome—APS

 

June is APS awareness month – APS, the acronym for Antiphospholipid Syndrome, the blood clotting disorder that caused my stroke nine years ago.

I remember feeling like the doomed heroine of a bad sci-fi when I first learned the cause of my stroke – an unpronounceable, incomprehensible disease: ‘Antiphospholipid Syndrome,’ or APS.

I’d never heard of APS. Nobody I knew had ever heard of APS, even most of my doctors had never heard of APS.

You may not have heard about APS, either, but you need to know. Here’s why:

  • One third of strokes occurring in people under 50 are due to APS.  Mine was one of those.
  • Estrogen in the form of birth control pills and hormone replacement–perfectly safe for most women–can be deadly for women with APS.
  • 15-20% of blood clots in large veins (deep vein thrombosis, including pulmonary embolism) are caused by APS.
  • 10-25% of women with recurrent miscarriages have APS.  If properly diagnosed and treated, many of them will be able to deliver healthy babies
  • APS is a major women’s health issue: 75-90% of those affected by APS are women
  • APS isn’t rare. It’s estimated that one to five percent of the general population has APS.  That’s about two to six million women, comparable to the number of women living with cancer.

 

Here are the facts:

  • APS is a blood clotting disorder. In patients with APS, the body releases antibodies that cause the blood to clot when it shouldn’t
  • As a result, APS is a common cause of miscarriage, blood clots in the legs (deep vein thrombosis), the lungs (pulmonary embolism), and stroke.
  • It’s also an autoimmune disease. Like lupus and other autoimmune diseases, APS can “flare” at times, causing weakness, fatigue, achy muscles and joints, especially when we’re are tired or stressed.
  • APS is sometimes found in conjunction with other autoimmune diseases, particularly as lupus.

Awareness is growing. When I started trying to research APS in 2002, shortly after my stroke, the only information I could find was a booklet from the Hughes Foundation in England and Medline articles heavy on doctor-speak.  Today, lots of information is available from the APS Foundation of America as well as trusted medical sites like the Mayo Clinic, the National Institute of Neurological Disorders and Stroke (NINDS), and genome.gov.  APS now even has its own Wikipedia page.

There are also several on-line support groups: the Antiphospholipid Syndrome International Support Group (APLSUK) based in the UK, and APS-Syndrome, both run through YAHOO, and the support forum sponsored by the APS Foundation of America.

Be informed and share information about APS with the women in your life.

 

Vitamin D Deficiency May Increase Risk of Clots in APS Patients

When I feel the sniffles coming on, I always reach for some extra vitamin C. And as an autoimmune patient with Antiphospholipid Syndrome (APS) I know to get plenty of rest. But until a few years ago, I’d never thought about Vitamin D. I don’t think my doctors paid much attention to it, either, until research began to show that Vitamin D deficiency is common in the US, and can be especially severe in autoimmune patients.
[frame_left]

[/frame_left]
Once we started checking my Vitamin D levels, we found they were off the chart low. I’d take supplements for a while, but the D would drop back down into the red zone every time I stopped. So the docs and I surrendered and added Vitamin D supplements to my regimen.

A funny thing happened then: I began to feel better. I noticed fewer of those classic autoimmune “flares”–puffy hands, aching joints–days when it hurt just get out of bed; days when I wanted a nap just from the effort of taking a shower. When my D was up, I seemed to have more energy, higher stamina, more enthusiasm. I mentioned this to my docs. No one could think of a reason that Vitamin D should reduce flares but, hey, I took it for the blessing it was.

Now new research is showing is showing at Vitamin D may be more important–especially for Antiphospholipid syndrome patients–than anyone knew.

A new study published in the Annals of the Rheumatic Diseases has found that vitamin D deficiency might be associated with increased coagulation–and attendant risk of blood clots–in APS. The study recommends that APS patients have their Vitamin D levels tested, and, if warranted, take supplements.

Extra protection against stroke and other blood clots from a little green gelcap? I’ll take that any day

Other Resources:

Vitamin D: an instrumental factor in the antiphospholipid syndrome

What Do You Lack? Probably Vitamin D By JANE E. BRODY, New York Times
Published: July 26, 2010

Vitamin D promises to be the most talked-about and written-about supplement of the decade …

If you have APS or another autoimmune disease, be sure to check your vitamin D regularly.